Race in Bottle - Columbia University Press Blog

January 18, 2013

Read an Excerpt from our Book of the Week: Jonathan Kahn's Race in a Bottle

This week, we’ve brought you an interview and author post from Jonathan Kahn, Hamline Law Professor and expert on BiDil, the first race-specified drug approved by the FDA (click here for the story of BiDil). To wrap up our feature...

January 17, 2013

Jonathan Kahn – Is the Patent Office Forcing Race into Biotechnology Patents?

One of the most significant things you’ll learn from Jonathan Kahn’s new book, Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age, is that racial discourse surfaces within most all of the vertically integrated...

January 16, 2013

An Interview with Race in a Bottle author Jonathan Kahn

Earlier this week, we posted on BiDil, the first FDA-approved drug with a race-specific indication on its label. In the following interview with Columbia University Press, Jonathan Kahn, author of Race in a Bottle: The Story of BiDil and Racialized...

January 15, 2013

The Story of BiDil: the FDA's First Race-Specific Drug

Hamline University Law Professor Jonathan Kahn has become a prominent critical voice in the last decade on the controversial injection of racial discourse into American medical practice (particularly in the realm of genetically tailored drugs). In the following post, he...

November 8, 2012

Jonathan Kahn on Genetic Technologies and Their Impact on Society

Jonathan Kahn, author of Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age, is a frequent speaker at the Tarrytown meetings, an annual meeting of the Center for Genetics and Society in which scientists...

S	M	T	W	T	F	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Tag: Race in Bottle

Read an Excerpt from our Book of the Week: Jonathan Kahn's Race in a Bottle

Jonathan Kahn – Is the Patent Office Forcing Race into Biotechnology Patents?

An Interview with Race in a Bottle author Jonathan Kahn

The Story of BiDil: the FDA's First Race-Specific Drug

Jonathan Kahn on Genetic Technologies and Their Impact on Society